Offer Type
Offered
Condition
New
When evaluating the safety of Sildigra 100 Mg, several factors warrant consideration. Patients with underlying heart conditions, such as coronary artery disease or hypertension, may face heightened risks and require closer monitoring. Additionally, concomitant use of nitrate medications, commonly prescribed for heart conditions, can potentiate the vasodilator effects of Sildigra 100 Mg, posing a significant risk of hypotension and cardiovascular complications. Dosage adjustments and careful medication reconciliation are paramount in mitigating these risks.